Mark Schoenebaum, Evercore ISI analyst, discusses his thoughts on the biotech rally. » Read More
Stocks opened slightly higher, bouncing off a rough day Monday but moving hesitantly as an economic report showed consumer weakness continues to hamper growth.
In yesterday's extension of the current rally, three more Dow stocks crossed above their 200-day moving averages. There are now seven stocks on the Dow above this technical threshold.
Against the backdrop of President Obama's healthcare reform effort, the main lobbying group for the generic drug industry says the U.S. healthcare system saved nearly three-quarters of a trillion dollars over the past ten years on generic drugs.
Cramer explains why the market stalled today and what we need to go higher.
Following are the “Fast & Furious” trades - hot ways to play Wednesday's market moving events.
Don't get so swept up in trying to predict where specific stocks are going that you ignore what they're saying about the market as a whole.
Stock action in the last week of the month supports bull position. Remember the bull position: that the great decline in stock prices, combined with government support, along with economic news that will prove to be "less bad" as the months go on, is providing a floor under the stock market.
The swine flu epidemic remains a wild card, as no one is quite certain how far the epidemic will spread.
Following are the “Fast & Furious” trades - hot ways to play tomorrow's market moving events.
Stocks bounced back from a swine flu-induced drop Monday as traders scooped up shares of drug makers and pharmacies.
Swine Flu: global pandemic or paranoia? President Obama said the health emergency declaration was merely a prudent measure. But many pharmaceutical stocks were sharply higher Monday in reaction to flu outbreaks — and the gains seemed to ripple through the sector.
Following are the “Fast & Furious” trades - hot ways to play tomorrow's market moving events. Also you'll find the gang's "Final Trades" here.
Stocks ended higher Friday after better-than-expected results from Ford but ended lower for the week, snapping a six-week winning streak. recovered Friday after a drop triggered by the release of the bank stress-test results.
As stocks capped a seventh consecutive week of gains, traders Marty Cunningham of Solazzo Trading Company and Michael Gurka of First Street Capital Partners considered how much room remains for the rally.
At Pfizer's annual shareholder meeting in Atlanta this morning, investors approved a version of "Say on Pay."
CNBC’s Mike Huckman is keeping a close eye on Big Pharma earnings. And he suggests you do the same - because he's spotted a devil the details.
Not a surprise, but my post yesterday on what one reader called the analyst "flip-flop" on Dendreon generated a lot of responses and queries.
In this Web Extra, Pete Najarian talks Pharma takeovers. What's on his radar?
Following are the day’s biggest winners and losers. Find out why shares of Yum! Brands and Piper Jaffray popped while Microsoft and Abbott Labs dropped.
Oh, the fun the late-night comics could have with this one. The makers of the little blue pill are a little red-faced on the Emerald Isle.